tebu-bio to provide Sanguine BioSciences' product range throughout Europe

Sept. 1, 2011 - PRLog -- tebu-bio now brings European researchers access to Sanguine BioSciences’ range of Human PBMC, Primary Cells and Stem Cells.

tebu-bio has a well-established pan-European presence, recognised by the international scientific community, with local offices in France, Germany, Belgium, the Netherlands, Italy, Denmark, Portugal, Spain and the UK.

Brian Neman, CEO, Sanguine BioSciences (Santa Monica, CA, USA) commented on the deal: "We are excited about our partnership with tebu-bio. Our company has evaluated multiple opportunities that could potentially assist in our presence in Europe, and tebu-bio has been at the top of the list in every category in our consideration of a potential European distribution partner. We look forward to their distribution of Sanguine's Human Primary Mononuclear Cells and, in the next few months, Mononuclear Cells and other biospecimens from patient-donors diagnosed with Autoimmune and Neurodegenerative malignancies.”

Gladys Verelst, Marketing specialist at tebu-bio (Le Perray-en-Yvelines, France) says: “We are very pleased to be able to offer our clients throughout Europe access to these high quality products. They will prove an added value to our blood product range and provide scientists with new products applicable in a wide research area of assay development, target-drug & toxicity screening, biomarker identification & characterisation, immune response monitoring etc.".

To find out more about Sanguine BioSciences’ products available from tebu-bio, visit http://www.tebu-bio.com

About Sanguine BioSciences:
Sanguine BioSciences provides highly viable primary human cells and tissues to the academic and industrial life science research community. The product offering spans customers’ needs mainly in the In Vitro Research & Development stage of Drug Development. The organization hold proprietary cryopreservation technology that allows for >90% post-thaw viability of primary human cells and tissues. Sanguine’s vision is to develop into the global leader in high quality cells and tissues for life science research and development.
Sanguine is based in Santa Monica, California, and is a portfolio company of Los Angeles Syndicate of Technology www.last.vc, a venture capital fund that specializes in early-stage internet-technology and biotechnology companies.

About tebu-bio:
tebu-bio is an expert in the supply and distribution of reagents for Life Sciences research in Europe and has its own R&D laboratories providing contract services. Our tebu-bio.com catalogue provides access to the most innovative range of products.

# # #

tebu-bio is an expert in the supply & distribution of Life Sciences Lab Services & Reagents throughout Europe. Their own laboratories also provide R&D contract services. Their on-line catalogue at http://www.tebu-bio.com offers access the most innovative range of over 620 000 references.